Home > Drug Search >
  • company_query: Biosidus
  •   > 
Drug Filter
Category:
chemistry (3) biology (25)
Status:
Approved (6) NDA Filing (1) Phase Ⅲ (3) Phase Ⅱ (13) Phase Ⅰ (5)
Clinical Stage:
Pending (1) Active (21)
Bio-Type:
Gene therapy (2) Vaccine (5) Blood extraction (2) Recombinant cytokines (5)
Indication:
Acute lymphoblastic leukaemia (ALL) (1) Amyotrophic lateral sclerosis (ALS) (1) Anemia (2) Bladder cancer (1) Breast cancer (2) Chronic myeloid leukemia (CML ) (1) ischaemic heart disorder (1) Cutaneous T cell lymphoma (CTCL) (1) Duchenne muscular dystrophy (DMD) (1) Epidermolysis bullosa (1) Gastric cancer (1) HBV infection (1) HCV infection (1) Melanoma (3) Multiple myeloma (MM) (2) Multiple sclerosis (MS) (2) Non small cell lung cancer (NSCLC) (1) Ovarian cancer (1) Lactose intolerance (1) Solid tumours (3) Rotavirus infection (1) Head and neck cancer (2) Colorectal cancer (1) Stroke (1) B-cell lymphoma (1) Neutropenia (2) Peritoneum cancer (1) Sporadic inclusion body myositis (sIBM) (1) Merkel cell carcinoma (1) Glioblastoma (1) Systemic sclerosis (1) Muscle spasticity (1) Celiac disease (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top